Early day motion tabled by primary sponsor Lord Cryer (Labour), on Tuesday, 11 October 2016, in the House of Commons. It is signed by 68 members in total.
NIVOLUMAB
That this House notes that NICE has failed to approve the anti-cancer drug Nivolumab for use in England, whereas the drug is already being prescribed in Scotland; further notes that Nivolumab is known as the wonder drug by many clinicians due to its success; congratulates Terri Robson of Leyton and her family and supporters for raising more than 170,000 signatures on a petition calling for Nivolumab to be prescribed in England; and calls on NICE to review urgently its decision for the sake of thousands of patients who are desperately in need of Nivolumab.
Secondary information
- Type
- Early day motion
- Reference
- 512
- Session
- 2016-17
- Other sponsors
- Ronnie Campbell
- Mark Durkan
- Jonathan Edwards
- Ian Mearns
- Jim Shannon
- Subjects
- Health services Diseases
- Link
- View this Early day motion on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-10-15 18:14:56 +0100
- URI
- http://data.parliament.uk/edms/49764
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/edms/49764
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/edms/49764